HomeStock ScreenerPine LabsIntrinsic Value

Pine Labs Intrinsic Value

Pine Labs (PINELABS) median intrinsic value is ₹58.11 from 3 valuation models (range ₹58–₹58), vs current price ₹193.71 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Also explore PINELABS price movement history to track price trends across different timeframes.

Current Stock Price
₹193.71
Primary Intrinsic Value
₹58.11
Market Cap
₹N/A
-70.0% Downside
Median Value
₹58.11
Value Range
₹58 - ₹58
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

PINELABS Valuation Methods Summary — DCF, Graham Number & P/E

Pine Labs intrinsic value across 3 models vs current price ₹193.71 — upside/downside and value range per method. For current market price and key ratios, visit PINELABS share price.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹58.11 ₹46.49 - ₹69.73 -70.0% EPS: ₹0.24, Sector P/E: 12x
PEG Ratio Method growth ₹58.11 ₹52.30 - ₹63.92 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹58.11 ₹52.30 - ₹63.92 -70.0% Revenue Growth: 6.0%, Adj P/E: 8.2x
Method Types: Earnings Asset DCF Growth Dividend Conservative

PINELABS Intrinsic Value vs Market Price — All Valuation Models

Pine Labs fair value range ₹58–₹58 vs current market price ₹193.71 across 3 valuation models. Browse Pine Labs annual reports for revenue, profit, balance sheet and cash flow data.

PINELABS Intrinsic Value Analysis — Undervalued or Overvalued?

Pine Labs median intrinsic value ₹58.11, current price ₹193.71 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of PINELABS?

Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Pine Labs (PINELABS) is ₹58.11 (median value). With the current market price of ₹193.71, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹58.11 to ₹58.11, indicating ₹58.11 - ₹58.11.

Is PINELABS undervalued or overvalued?

Based on our multi-method analysis, Pine Labs (PINELABS) appears to be trading above calculated value by approximately 70.0%.

PINELABS Financial Health — Key Ratios vs Industry Benchmarks

Pine Labs financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 32.19 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 0.7% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 12.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 0.25x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

PINELABS Cash Flow Quality — Operating & Free Cash Flow

Pine Labs operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹50 Cr ₹-193 Cr Positive Operating Cash Flow 6/10
March 2024 ₹-229 Cr ₹-240 Cr Negative Cash Flow 3/10
March 2023 ₹-152 Cr ₹-373 Cr Negative Cash Flow 3/10
March 2022 ₹-79 Cr ₹-301 Cr Negative Cash Flow 3/10
March 2021 ₹111 Cr ₹-19 Cr Positive Operating Cash Flow 6/10